Life
Briefing: U.K. to Reassess Cost-Effectiveness of Alzheimer's Drugs
Strategic angle: Following successful appeals from drugmakers, the U.K. is reviewing the cost-effectiveness of two new Alzheimer's treatments.
Editorial Staff 22 days ago